Directory

>

Daniel Erlanson

Daniel Erlanson

Chief Innovation Officer | Frontier Medicines

San Francisco, California, United States

View contact details (it's free)

Daniel Erlanson

Summary

Daniel Erlanson is a seasoned professional in the field of commercial physical research, currently serving as the Chief Innovation Officer at Frontier Medicines. With a strong academic background in Chemistry, including a PhD from Harvard University, Daniel has cultivated a robust career spanning over two decades in various roles, including VP of Chemistry and Senior VP of Innovation and Discovery. His leadership has been instrumental in driving innovation and discovery in the pharmaceutical sector. Daniel co-founded Carmot Therapeutics, showcasing his entrepreneurial spirit and commitment to advancing scientific research. He has a proven track record of long-term tenure in organizations, indicating a strong commitment to his roles. His experience in both startup and corporate settings enriches his perspective on innovation in the life sciences industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Daniel Erlanson

Work Experience

company logo

Chief Innovation Officer at

Frontier Medicines

January 2024 - Present

company logo

Senior VP of Innovation and Discovery at

Frontier Medicines

January 2022 - January 2024

company logo

VP of Chemistry at

Frontier Medicines

January 2019 - January 2022

company logo

Co-founder, Board Member, and VP of Chemistry at

Carmot Therapeutics

January 2008 - January 2019

company logo

Associate Director of Medicinal Chemistry at

Sunesis Pharmaceuticals, Inc.

January 2007 - January 2008

company logo

Senior Scientist at

Sunesis Pharmaceuticals, Inc.

January 2003 - January 2007

company logo

Staff Scientist at

Sunesis Pharmaceuticals, Inc.

January 2001 - January 2003

company logo

Scientist at

Sunesis Pharmaceuticals, Inc.

January 1999 - January 2001

company logo

NIH Postdoctoral Fellow at

Sunesis Pharmaceuticals, Inc.

January 1998 - January 1999

company logo

Postdoctoral Fellow at

Genentech

January 1997 - January 1998

Logos provided by Logo.dev

Daniel Erlanson

Education

Frequently Asked Questions about Daniel Erlanson

What is Daniel Erlanson email address?

Daniel Erlanson's primary email address is ***************@frontiermeds.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Daniel Erlanson work for?

Daniel Erlanson is a Chief Innovation Officer at Frontier Medicines, a company specializing in Commercial physical research.

Where Daniel Erlanson graduated from?

Daniel Erlanson holds a degree in Chemistry from Harvard University.

How can I directly contact Daniel Erlanson?

To contact Daniel Erlanson directly, you can use the email address ***************@frontiermeds.com. Complete contact information is available upon registration with Muraena.

Who is Daniel Erlanson?

Daniel Erlanson is a seasoned professional in the field of commercial physical research, currently serving as the Chief Innovation Officer at Frontier Medicines. With a strong academic background in Chemistry, including a PhD from Harvard University, Daniel has cultivated a robust career spanning over two decades in various roles, including VP of Chemistry and Senior VP of Innovation and Discovery. His leadership has been instrumental in driving innovation and discovery in the pharmaceutical sector. Daniel co-founded Carmot Therapeutics, showcasing his entrepreneurial spirit and commitment to advancing scientific research. He has a proven track record of long-term tenure in organizations, indicating a strong commitment to his roles. His experience in both startup and corporate settings enriches his perspective on innovation in the life sciences industry.

Daniel`s contact details

mail

***************@frontiermeds.com

Colleagues

avatar
Norbert Schuehler

VP, Information Technology

avatar
Snahel Patel

Vice President, Head of Chemistry

avatar
Sylvia

Chief Of Staff

avatar
Roberto Zoncu

Co-director, Molecular Therapeutics Initiative

Doug Burdette

Vice President of DMPK

avatar
Daniel Nomura

Co-Founder

avatar
Tina Gullotta

Vice President Finance

Kevin Webster

Chief Science Officer

avatar
Johannes Hermann

Chief Technology Officer

avatar
Victoria Fort

Senior Vice President, Strategy and Corporate Affairs

View Contact details (it's free)
Request Profile Removal